{
    "Trade/Device Name(s)": [
        "Premier CAMPY"
    ],
    "Submitter Information": "Meridian Bioscience, Inc.",
    "510(k) Number": "K083464",
    "Predicate Device Reference 510(k) Number(s)": [
        "K982315"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "LQP"
    ],
    "Summary Letter Date": "December 15, 2008",
    "Summary Letter Received Date": "December 19, 2008",
    "Submission Date": "November 18, 2008",
    "Regulation Number(s)": [
        "21CFR866.3110"
    ],
    "Regulation Name(s)": [
        "Campylobacter fetus serological reagents"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Campylobacter jejuni",
        "Campylobacter coli"
    ],
    "Specimen Type(s)": [
        "Stool"
    ],
    "Specimen Container(s)": [
        "Unpreserved container",
        "Cary Blair-based transport media"
    ],
    "Instrument(s)/Platform(s)": [
        "General laboratory spectrophotometer",
        "General laboratory semiautomated washer"
    ],
    "Method(s)/Technology(ies)": [
        "Enzyme immunoassay (EIA)",
        "Microwell-based immunoassay"
    ],
    "Methodologies": [
        "Qualitative detection of microbial antigens",
        "Antibody-based immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Control",
        "Consumable"
    ],
    "Document Summary": "FDA 510(k) summary for Premier CAMPY enzyme immunoassay for qualitative detection of Campylobacter antigens in human stool samples",
    "Indications for Use Summary": "Qualitative detection of Campylobacter jejuni and C. coli antigens in stool samples from patients with signs and symptoms of gastroenteritis; intended for hospital, reference, or state laboratory settings, not for point-of-care use",
    "fda_folder": "Microbiology"
}